Bacterial cytotoxins, amphotericin B and local anesthetics enhance transbilayer mobility of phospholipids in erythrocyte membranes. Consequences for phospholipid asymmetry.
Incorporation of the channel-forming polyene antibiotic amphotericin B and of cytotoxins from Staphylococcus aureus (alpha-toxin) or Pseudomonas aeruginosa into erythrocyte membranes results in a concentration-dependent enhancement of the flip rates of exogenous lysophosphatidylcholine. The flip rate is also enhanced by incorporation of tetracaine and dibucaine. Removal of tetracaine and amphotericin B from the cells normalizes the flip rates. In parallel to the enhancement of flip rates, alpha-toxin produces a loss of transmembrane asymmetry of both phosphatidylethanolamine and phosphatidylserine. Pretreatment of cells with amphotericin or high concentrations (over 2.5 mmol . l-1) of tetracaine, followed by removal of the perturbing agent by washing, produces a selective loss of the asymmetric orientation of phosphatidylethanolamine to the inner membrane layer, as evaluated by the accessibility of the lipid towards cleavage by phospholipase A2. The extent to which asymmetry is lost depends on the time of pretreatment with amphotericin or tetracaine, indicating a limitation by the rate of reorientation of phosphatidylethanolamine to the outer membrane surface. Evaluation of the accessibility of phosphatidylethanolamine towards cleavage by phospholipase A2 in the presence of local anesthetics indicates accessible fractions much higher than those obtained after removal of the perturbant. In the presence of tetracaine, endofacial phosphatidylethanolamine seems somehow to become accessible to phospholipase A2. Phosphatidylserine does not exhibit this peculiarity. The results indicate that various types of perturbation of the lipid domain of the erythrocyte membrane may enhance the transbilayer mobility of phospholipids as well as destabilize the asymmetric distribution of aminophospholipids. However, as in other instances reported previously (Haest, C.W.M., Erusalimsky, J., Dressler, V., Kunze, I. and Deuticke B. (1983) Biomed. Biochim. Acta 42, 17-21), there is no tight coupling between transbilayer mobility and destabilization of asymmetry of the transbilayer distribution of phospholipids.
Schneider
E
E
Haest
C W
CW
Plasa
G
G
Deuticke
B
B
D000666:Amphotericin B / Q000494:pharmacology*; D000779:Anesthetics, Local / Q000494:pharmacology*; D000818:Animals; D003603:Cytotoxins / Q000494:pharmacology*; D003992:Dibucaine / Q000494:pharmacology; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000378:metabolism*; D008563:Membrane Lipids / Q000378:metabolism*; D010714:Phosphatidylethanolamines / Q000378:metabolism; D010718:Phosphatidylserines / Q000494:pharmacology; D010741:Phospholipases A / Q000378:metabolism; D054467:Phospholipases A2; D010743:Phospholipids / Q000378:metabolism*; D011550:Pseudomonas aeruginosa; D011817:Rabbits; D051381:Rats; D013211:Staphylococcus aureus; D013748:Tetracaine / Q000494:pharmacology; D010738:Type C Phospholipases / Q000494:pharmacology
D000779:Anesthetics, Local; D003603:Cytotoxins; D008563:Membrane Lipids; D010714:Phosphatidylethanolamines; D010718:Phosphatidylserines; D010743:Phospholipids; D013748:Tetracaine; D000666:Amphotericin B; D010741:Phospholipases A; D054467:Phospholipases A2; D010738:Type C Phospholipases; D003992:Dibucaine